Hostname: page-component-68c7f8b79f-rgmxm Total loading time: 0 Render date: 2025-12-25T16:39:19.237Z Has data issue: false hasContentIssue false
  • English
  • Français

Reviewer Comment on O’Brien et al. “Pharmacological Management of Migraine by Primary Care Providers in Nova Scotia”

Published online by Cambridge University Press:  18 December 2025

Michelle Laneuville Open the ORCID record for Michelle Laneuville [Opens in a new window]
Michelle Laneuville*
Affiliation:
Department of Medicine, Division of Neurology, University of Ottawa, Ottawa, ON, Canada
*
Email: mlaneuville@toh.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Reviewer Comment
Information
Canadian Journal of Neurological Sciences , First View , pp. 1
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Safiri, S, Pourfathi, H, Eagan, A, et al. Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019. Pain. 2022;163(2):e293–309. DOI: 10.1097/j.pain.0000000000002275.10.1097/j.pain.0000000000002275CrossRefGoogle ScholarPubMed
Steiner, TJ, Stovner, LJ, Jensen, R, et al. Migraine remains second among the world’s causes of disability, and first among young women: Findings from GBD2019. J Headache Pain. 2020;21:137. DOI: 10.1186/s10194-020-01208-0.10.1186/s10194-020-01208-0CrossRefGoogle ScholarPubMed
Graves, EB, Gerber, BR, Berrigan, PS, et al. Epidemiology and treatment utilization for Canadian patients with migraine: A literature review. J Int Med Res. 2022;50(9):3000605221126380. DOI: 10.1177/03000605221126380.10.1177/03000605221126380CrossRefGoogle ScholarPubMed
O’Brien, MS, Grandy, M, Dawe, JA. Pharmacological management of migraine by primary care providers in Nova Scotia. Can J Neurol Sci. 1–18. DOI: 10.1017/cjn.2025.10472.Google Scholar
Medrea, I, Cooper, P, Langman, M, et al. Updated Canadian headache society migraine prevention guideline with systematic review and meta-analysis. Can J Neurol Sci. 2024;7:1–23. DOI: 10.1017/cjn.2024.285.Google Scholar